Cell Therapeutics Receives Remaining $5 million Under Existing Loan Financing Agreement

Cell Therapeutics (NASDAQ: CTIC ) today announced that CTI has received the remaining $5 million from Hercules Technology Growth Capital, Inc. (NYSE: HTGC ) available under the existing loan agreement that was established in March 2013. Further information with respect to this loan with Hercules will be available